Xiangming Li

Also affiliated with Sanofi (United States)

MedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy”.

PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy

The Journal of Experimental Medicine(2024)10.1084/jem.20231519

N/A

0DataRank · unranked

28 citations

Yufeng Xiao, Yuewan Luo, Rohan Master, Jiao Mo, Myung‐Chul Kim +17 more